Abiopharma

🔍 DUFFY BRIAN (Executive)

Company: Atlassian Corp (TEAM)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Sold 1,165 shares of Class A Common Stock at $164.2923 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 226,526.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 231 shares of Class A Common Stock at $165.1471 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 226,295.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 125 shares of Class A Common Stock at $166.4041 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 226,170.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 24 shares of Class A Common Stock at $167.2921 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 226,146.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 4,600 shares of Class A Common Stock at $162.3751 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 221,546.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,472 shares of Class A Common Stock at $163.2214 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 220,074.00 | transaction_form_type: 4 | Footnotes: F1, F7

Footnotes:

• F1: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
• F2: This transaction was executed in multiple trades during the day at prices ranging from $163.84 to $164.74. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
• F3: This transaction was executed in multiple trades during the day at prices ranging from $164.89 to $165.52. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
• F4: This transaction was executed in multiple trades during the day at prices ranging from $166.05 to $166.97. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
• F5: This transaction was executed in multiple trades during the day at prices ranging from $167.05 to $167.75. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
• F6: This transaction was executed in multiple trades during the day at prices ranging from $161.84 to $162.83. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
• F7: This transaction was executed in multiple trades during the day at prices ranging from $162.84 to $163.83. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.